Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 4Glioma 3Wilms Tumor 2Prostatic Neoplasms 2Glioblastoma 2Carcinoma, Intraductal, Noninfiltrating 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Solitary Fibrous Tumor, Pleural 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pancreatic Intraductal Neoplasms 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neuroblastoma 1Neoplasms 1Metastatic Malignant Female Reproductive System Neoplasm 1Mesothelioma, Malignant 1Lung Neoplasms 1Head and Neck Neoplasms 1Germinoma 1Ganglioneuroblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Ependymoma 1Down Syndrome 1Diabetes Insipidus 1Central Nervous System Nongerminomatous Germ Cell Tumor 1Central Nervous System Neoplasms 1

Interventions

tremelimumab 1durvalumab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Immunoglobulin G 1Disulfides 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metastatic Malignant Female Reproductive System Neoplasm × Radiotherapy, Conformal × 1 year × Clear all
NCT04516135 2026-02-25

Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
28 enrolled

Metastatic Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡